Skip to main content
Livermore
Livermore
ZHEN

Ellevest, Inc.

SEC CIK
0001644128
Latest filing
Aug 10, 2026

REGN holding history

Regeneron Pharmaceuticals, Inc. in every 13F filed by Ellevest, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

REGN overviewAll 13F holders of REGNFull Q2 2026 holdings

Shares (Q2 2026)
562
Value
$353.0K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of REGN by Ellevest, Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026562$353.0K<0.1%−69−10.9%ReducedHolders
Q1 2026631$487.5K0.1%−278−30.6%ReducedHolders
Q4 2025909$701.6K0.1%−202−18.2%ReducedHolders
Q3 20251,111$624.7K0.1%+260+30.6%AddedHolders
Q2 2025851$446.8K0.1%+464+119.9%AddedHolders
Q1 2025387$245.4K<0.1%−155−28.6%ReducedHolders
Q4 2024542$386.1K<0.1%+202+59.4%AddedHolders
Q3 2024340$357.4K<0.1%+33+10.7%AddedHolders
Q2 2024307$322.7K<0.1%−6−1.9%ReducedHolders
Q1 2024313$301.3K<0.1%+4+1.3%AddedHolders
Q4 2023309$271.4K<0.1%−75−19.5%ReducedHolders
Q3 2023384$316.0K<0.1%−232−37.7%ReducedHolders
Q2 2023616$442.6K<0.1%+127+26.0%AddedHolders
Q1 2023489$401.8K<0.1%+81+19.9%AddedHolders
Q4 2022408$294.4K<0.1%+11+2.8%AddedHolders
Q3 2022397$273.0K<0.1%−43−9.8%ReducedHolders
Q2 2022440$260.0K<0.1%+6+1.4%AddedHolders
Q1 2022434$303.0K<0.1%+207+91.2%AddedHolders
Q4 2021227$143.0K<0.1%+1+0.4%AddedHolders
Q3 2021226$137.0K<0.1%+33+17.1%AddedHolders
Q2 2021193$108.0K<0.1%+178+1,186.7%AddedHolders
Q1 202115$7.00K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.